本员工持股计划以"份"作为认购单位，1份额为1.00元，员工持股计划的总份数为不超过4,514.78万份。 本员工持股计划的参与对象所认购的具体份额根据实际出资缴款金额确定。资金来源为员工合法薪酬、 自筹资金和法律、行政法规允许的其他方式。本员工持股计划的最终参与人员和最终份额分配情况以实 际执行情况为准。 格隆汇9月5日丨弘元绿能(603185.SH)公布2025年员工持股计划，本员工持股计划规模不超过388.8698万 股，约占公司当前股本总额的0.57%。员工持股计划具体受让股份数量以实际执行情况为准确定。其 中，拟首次受让216.0207万股，占本员工持股计划标的股票总量的55.55%，占公司当前股本总额的 0.32%；预留172.8491万股，占本员工持股计划标的股票总量的44.45%，占公司当前股本总额的0.25%。 ...

Core Viewpoint - The company has conducted a thorough review of its 2025 Employee Stock Ownership Plan (ESOP) and has determined that it complies with relevant laws and regulations, aiming to enhance employee engagement and long-term value for shareholders [1][2]. Summary by Sections Legal Compliance - The company confirms that there are no prohibitive circumstances under the relevant laws and regulations for implementing the ESOP [1]. - The procedures for drafting the 2025 ESOP and related documents are legal and effective, adhering to the guidelines set forth in the relevant regulatory documents [2]. Employee Engagement - The ESOP has been developed with full consultation from employee representatives, ensuring that the decision-making process is legitimate and does not harm the interests of the company or its shareholders [2]. - Participation in the ESOP is voluntary, with no coercive measures employed to compel employees to join [2]. Benefits of the ESOP - The implementation of the ESOP is expected to foster a mechanism for sharing achievements and risks between talented employees and shareholders, enhancing employee ownership mentality [2]. - The plan aims to optimize the compensation structure and effectively allocate short, medium, and long-term incentive resources to attract, retain, and motivate outstanding talent, thereby promoting the company's long-term stability and increasing shareholder value [2].

Group 1 - The company held its 10th meeting of the 4th Board of Directors on August 29, 2025, with all 7 directors present, meeting the legal requirements [1][2] - The Board approved the draft of the 2025 Employee Stock Ownership Plan (ESOP) to enhance talent retention and align employee interests with shareholder value [2][3] - The voting result for the ESOP was unanimous, with 6 votes in favor and no opposition, representing 100% of the votes cast [3][4] Group 2 - The company plans to implement a 2025 Restricted Stock and Stock Option Incentive Plan to attract and retain talent while ensuring alignment of interests among shareholders, the company, and employees [5][6] - The voting result for the incentive plan was also unanimous, with 6 votes in favor and no opposition, representing 100% of the votes cast [6][7] - The Board proposed to authorize the shareholders' meeting to grant the Board the authority to manage the implementation of the incentive plan, including adjustments based on policy changes [7][8] Group 3 - The company will submit the ESOP and the incentive plan for approval at the upcoming shareholders' meeting [3][4] - The Board will also seek authorization to handle necessary administrative tasks related to the incentive plan, including approvals and registrations with relevant authorities [8][9] - The company aims to ensure the effective implementation of both plans to support its long-term development strategy [5][6]

Core Viewpoint - The Supervisory Board of Shenzhen Kaili Biomedical Technology Co., Ltd. has reviewed the 2025 Employee Stock Ownership Plan and concluded that it complies with relevant laws and regulations, and will not harm the interests of the company or its shareholders [1][2]. Summary by Sections Compliance and Legality - The company does not fall under any prohibitive conditions for implementing the employee stock ownership plan as per the relevant guidelines and regulations [1]. - The procedures for drafting the 2025 Employee Stock Ownership Plan and related documents are legal and effective [2]. Employee Involvement - The plan has been developed with sufficient consultation from employee representatives, ensuring that the decision-making process is legal and does not harm the interests of the company or its shareholders [2]. Eligibility and Benefits - The proposed participants in the employee stock ownership plan meet the eligibility criteria set forth in the relevant guidelines and regulations [2]. - Implementing this plan is expected to foster a mechanism for sharing achievements and risks between talented employees and shareholders, enhancing employee engagement, optimizing compensation structures, and promoting long-term stable development and shareholder value [2].

Group 1 - The company held the ninth meeting of the fourth supervisory board, which was legally valid with all three supervisors present [1] - The supervisory board unanimously approved the 2025 Employee Stock Ownership Plan, confirming its compliance with relevant laws and regulations [2][3] - The board believes that the employee stock ownership plan will enhance corporate governance and create a balanced value distribution system, benefiting the company's sustainable development [2][3] Group 2 - The supervisory board also approved the 2025 Restricted Stock and Stock Option Incentive Plan, which aligns with legal requirements and aims to attract and retain talent [3][4] - The plan is designed to integrate the interests of shareholders, the company, and employees, promoting long-term development without harming the interests of the company and its shareholders [3][4] - The board confirmed that there are no prohibitive circumstances for implementing the incentive plan, and the company is qualified to proceed [3][4] Group 3 - The 2025 Incentive Plan Management Measures were approved to ensure the plan's smooth implementation and compliance with legal standards [4] - The assessment indicators for the incentive plan are deemed scientific and reasonable, aimed at achieving the plan's objectives and enhancing corporate governance [4] - The board will publicly disclose the list of incentive plan participants before the shareholders' meeting, ensuring transparency [6]

Meeting Information - The company will hold its first extraordinary general meeting of shareholders for 2025 on September 23, 2025, at 14:30 [1] - Voting will be conducted both on-site and through an online voting system provided by the Shenzhen Stock Exchange [2] Voting Procedures - Shareholders can choose either on-site voting or online voting, but not both. Duplicate votes will be counted based on the first submission [2][6] - The registration deadline for shareholders is September 17, 2025, at the close of trading [2] Agenda Items - The meeting will discuss several proposals, including the authorization of the board to handle matters related to the 2025 employee stock ownership plan and the 2025 restricted stock and stock option incentive plan [3][4] - Proposals requiring special resolutions need to be approved by more than two-thirds of the voting rights held by attending shareholders [3] Registration and Attendance - Legal representatives of corporate shareholders must present specific documentation to register for the meeting [4][5] - Individual shareholders must also provide identification and shareholder account information for registration [5] Online Voting Process - Detailed procedures for participating in online voting are provided, including the need for identity verification through the Shenzhen Stock Exchange's systems [6]

Group 1 - The core opinion of the legal opinion letter is that the employee stock ownership plan (ESOP) proposed by Shenzhen Kaili Biomedical Technology Co., Ltd. complies with relevant laws and regulations, including the Company Law and Securities Law [2][11][16] - The company has fulfilled the necessary legal procedures for implementing the ESOP, including soliciting employee opinions and obtaining board and supervisory board approvals [12][13][15] - The ESOP is designed to allow employees, including core management, to voluntarily participate, ensuring compliance with the principle of voluntary participation [5][14] Group 2 - The ESOP will be funded through employees' legal salaries, self-raised funds, and other legally permitted means, without the company providing financial assistance or guarantees [5][6] - The total number of shares allocated under the ESOP will not exceed 500,000 shares, representing 0.12% of the company's total equity, with a total funding amount not exceeding 7.965 million yuan [6][8] - The ESOP has a duration of 60 months and a lock-up period of 48 months, with shares vesting in four equal installments [7][8] Group 3 - The management committee will oversee the ESOP, ensuring the protection of participants' rights and compliance with market trading rules [10][11] - The ESOP will not allow forced participation and will adhere to the principle of self-determination for employees [14][15] - The company is required to continuously disclose information regarding the progress of the ESOP in accordance with regulatory requirements [16]

Core Viewpoint - The company has developed a draft for the 2025 Employee Stock Ownership Plan (ESOP) in compliance with relevant laws and regulations, aiming to enhance employee engagement and long-term development [1][2]. Group 1: Compliance and Eligibility - The company confirms that it does not fall under any prohibitive conditions outlined in the relevant guidelines, thus qualifying to implement the ESOP [1]. - The content of the ESOP aligns with the regulations set forth in the guidelines, and employee opinions were thoroughly solicited prior to its introduction [1]. Group 2: Decision-Making Process - The board of directors ensured that related directors recused themselves from voting on the ESOP, validating the legality and effectiveness of the decision-making process [2]. - The remuneration and assessment committee verified that all proposed participants meet the eligibility criteria as per the guidelines, ensuring voluntary participation without coercion [2]. Group 3: Benefits of the ESOP - The implementation of the ESOP is expected to foster a mechanism for sharing achievements and risks between talented employees and shareholders, enhancing employee ownership mentality and optimizing compensation structures [2]. - The plan aims to attract, retain, and motivate outstanding talent, thereby promoting the company's long-term stability and increasing shareholder value [2].

证券简称：开立医疗 证券代码：300633 深圳开立生物医疗科技股份有限公司 （草案） 声明 本公司及全体董事保证本员工持股计划草案及其摘要不存在虚假记载、误 导性陈述或重大遗漏，并对其真实性、准确性、完整性承担个别和连带的法律 责任。 风险提示 否获得公司股东大会批准，存在不确定性； 在不确定性； 完成实施，存在不确定性； 资金较低，则本员工持股计划存在不能成立的风险；若员工认购资金不足，则 本员工持股计划存在低于预计规模的风险； 动，投资者对此应有充分准备。 意投资风险。 特别提示 施员工持股计划试点的指导意见》《深圳证券交易所上市公司自律监管指引第 及《公司章程》的规定制定。 派、强行分配等强制员工参加本员工持股计划的情形。 独立董事）、高级管理人员及核心管理人员。拟参与本员工持股计划的员工总 人数不超过 7 人，其中董事（不含独立董事）、高级管理人员 3 人，其他员工 不超过 4 人，具体参与人数以实际自愿参加的员工及其参与情况为准。 股票。本持股计划经公司股东大会审议通过后，将通过非交易过户等法律法规 允许的方式获得公司回购专用证券账户所持有的公司股份。 持股计划董事会决议日至标的股票过户至本持股计 ...

Core Viewpoint - Shenzhen Sunlord Electronics Co., Ltd. held its first meeting of the fifth employee stock ownership plan on September 4, 2025, where key resolutions were passed regarding the establishment and management of the plan [1][2]. Group 1: Establishment of Management Committee - The meeting approved the establishment of the management committee for the fifth employee stock ownership plan, which will oversee the daily management of the plan [1][3]. - The management committee consists of five members, including one chairperson, with a term that aligns with the duration of the employee stock ownership plan [1][3]. Group 2: Election of Committee Members - The meeting elected five individuals to the management committee: Mr. Shi Hongyang, Mr. Li Youyun, Mr. Li Yu, Mr. Xu Jia, and Ms. Ren Yi, with their terms also aligning with the plan's duration [2][3]. - Notably, Mr. Shi Hongyang, Mr. Li Youyun, and Mr. Li Yu hold 30% of the shares in a company that owns 6.88% of Sunlord's total shares, but they do not have any related party relationships with other major shareholders or executives [2][3]. Group 3: Authorization of Management Committee - The meeting authorized the management committee to handle various matters related to the employee stock ownership plan, including convening meetings and supervising daily management [3][5]. - Specific responsibilities include representing all holders in exercising shareholder rights, managing profit distribution, and handling inheritance registration of stock ownership [5][6].